Li WY - Search Results

1

Cancer-associated fibroblasts promote the progression and chemoresistance of HCC by inducing IGF-1.

Lv KJ, Yu SZ, Wang Y, Zhang SR, Li WY, Hou J, Tan DL, Guo H, Hou YZ. Lv KJ, et al. Among authors: li wy. Cell Signal. 2024 Dec;124:111378. doi: 10.1016/j.cellsig.2024.111378. Epub 2024 Sep 4. Cell Signal. 2024. PMID: 39241901 Free article.

2

P57-mediated autophagy promotes the efficacy of EGFR inhibitors in hepatocellular carcinoma.

Li WY, Li Q, Jing L, Wu T, Han LL, Wang Y, Yu SZ, Nan KJ, Guo H. Li WY, et al. Among authors: li q. Liver Int. 2019 Jan;39(1):147-157. doi: 10.1111/liv.13957. Epub 2018 Oct 8. Liver Int. 2019. PMID: 30178471

3

Role of cancer-associated fibroblasts in the resistance to antitumor therapy, and their potential therapeutic mechanisms in non-small cell lung cancer.

Chen C, Hou J, Yu S, Li W, Wang X, Sun H, Qin T, Claret FX, Guo H, Liu Z. Chen C, et al. Oncol Lett. 2021 May;21(5):413. doi: 10.3892/ol.2021.12674. Epub 2021 Mar 23. Oncol Lett. 2021. PMID: 33841574 Free PMC article. Review.

4

NT157 Inhibits HCC Migration via Downregulating the STAT3/Jab1 Signaling Pathway.

Yu S, Wang Y, Lv K, Hou J, Li W, Wang X, Guo H, Wang W. Yu S, et al. Technol Cancer Res Treat. 2021 Jan-Dec;20:15330338211027916. doi: 10.1177/15330338211027916. Technol Cancer Res Treat. 2021. PMID: 34238066 Free PMC article.

5

ASF1B is a Promising Prognostic Biomarker and Correlates With Immunotherapy Efficacy in Hepatocellular Carcinoma.

Zhang S, Xu L, Feng J, Tan D, Zhu Y, Hou J, Li W, Lv K, Wang W, Jiang L, Jiao M, Guo H. Zhang S, et al. Front Genet. 2022 Mar 10;13:842351. doi: 10.3389/fgene.2022.842351. eCollection 2022. Front Genet. 2022. PMID: 35360875 Free PMC article.

6

UHRF1 plays an oncogenic role in small cell lung cancer.

Hou J, Li W, Zhang S, Tan D, Lv K, Zhu Y, Hou Y, Guo H, Jiang L. Hou J, et al. Mol Carcinog. 2023 Mar;62(3):385-397. doi: 10.1002/mc.23493. Epub 2022 Dec 20. Mol Carcinog. 2023. PMID: 36537722

7

Tumor-infiltrating immune cells in hepatocellular carcinoma: Tregs is correlated with poor overall survival.

Yu S, Wang Y, Hou J, Li W, Wang X, Xiang L, Tan D, Wang W, Jiang L, Claret FX, Jiao M, Guo H. Yu S, et al. PLoS One. 2020 Apr 2;15(4):e0231003. doi: 10.1371/journal.pone.0231003. eCollection 2020. PLoS One. 2020. PMID: 32240238 Free PMC article.

8

A four-methylated mRNA signature-based risk score system predicts survival in patients with hepatocellular carcinoma.

Wang Y, Ruan Z, Yu S, Tian T, Liang X, Jing L, Li W, Wang X, Xiang L, Claret FX, Nan K, Guo H. Wang Y, et al. Aging (Albany NY). 2019 Jan 10;11(1):160-173. doi: 10.18632/aging.101738. Aging (Albany NY). 2019. PMID: 30631005 Free PMC article.

9

Characteristics of the immunogenicity and tumor immune microenvironment in HER2-amplified lung adenocarcinoma.

Wang Q, Mao Z, Li W, Wang S, Wang L, Chen L, Yang Z, Fu X, Jiang P, Bai Y, Xu L, Zhang S, Hou Y, Jia X, Jiang L, Liu M, Zhang G, Jiang Y, Guo H. Wang Q, et al. Front Immunol. 2022 Dec 15;13:1042072. doi: 10.3389/fimmu.2022.1042072. eCollection 2022. Front Immunol. 2022. PMID: 36591290 Free PMC article.

10

Stimuli-Responsive Aptamer-Drug Conjugates for Targeted Drug Delivery and Controlled Drug Release.

Zhu S, Gao H, Li W, He X, Jiang P, Xu F, Jin G, Guo H. Zhu S, et al. Adv Healthc Mater. 2024 Sep;13(23):e2401020. doi: 10.1002/adhm.202401020. Epub 2024 May 19. Adv Healthc Mater. 2024. PMID: 38742703

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,203 results

Search Page

Filters